Aktiesnakken — April 2010
-
stinger ! I like!
-
kan være et godt køb efter Roche (partneren) søger approval efter fase 2 resultater i brystcancer
http://www.roche.com/investors/ir_update/inv-update-2010-04-15.htm -
solsen har du noget på genmab?
-
er index ikke i plus?
-
@stinker og rituxian salg, lad os ikke glemme det parasitiære forhold der er mellem Ritux og Arzerra. Jo mere r
jo mere refrac jo mere a
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind